Oral med for obesity, stem cells after heart failure, blood markers and MS, and predicting atherosclerosis
<p data-rte-preserve-empty="true" style="white-space:pre-wrap;">Program notes:</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">0:37 An oral med for obesity</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">1:37 Five to 10% stopped medication</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">2:35 Need head-to-head trials with injectable</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">3:00 Stem cell infusion after MI and heart failure</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">4:01 Reduced heart failure in recipients</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">5:01 Twice as many in the control arm</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">6:01 Moving past BMI in predicting atherosclerosis</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">7:01 Especially in overweight but not obese</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">8:01 Almost 3000 participants in Brazil</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">8:25 Blood samples precede MS</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">9:04 Seen seven years beforehand</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">10:02 Twin studies and relatives</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">11:03 Way to intervene earlier</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">11:15 Applaud OpenAI</p><p class="MsoNormal" data-rte-preserve-empty="true" style="white-space:pre-wrap;">13:00 End</p>